Related Experiment Video
Updated: Feb 19, 2026

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
Melanotic Schwannomas Are Rarely Seen Pigmented Tumors with Unpredictable Prognosis and Challenging Diagnosis
Elif Keskin1, Sumeyye Ekmekci1, Ozgur Oztekin1
1Tepecik Education and Research Hospital, Izmir, Turkey.
Abstract:
Melanotic Schwannoma (MS) is rarely seen and potentially malignant neoplasm that is categorized as a variant of Schwannoma. MS most frequently involves intracranial structures followed by posterior nerve roots in the spinal canal. Approximately 50% of the cases with MS have psammomatous calcifications and this type of MS is related to Carney complex with autosomal dominant inheritance. Most cases of MS are benign, though 10% of them are malignant with metastatic potential. MS mimics melanoma and the differential diagnosis should be made excluding other melanin producing neoplasms especially melanoma. Case 1. A 42-year-old hypertensive male presented for checkup. He had a well-defined extraspinal oval lesion measuring 3.5 × 2.5 cm near right adrenal. Case 2. A 22-year-old female presented with neurofibromatosis-2, bilateral acoustic schwannomas and café au lait lesions on sacrococcygeal region. She had an intradural extramedullary lesion measuring 6.1 × 2.0 cm at L1-2 level. MS is a rare neoplasm composed of Schwann cells and melanin pigment. These tumors are usually benign but they may become aggressive. The biologic behavior of MS is difficult to predict; the patients have to be followed up for a longer period due to its malignant potential.
Insights
Melanotic Schwannoma (MS) is a rare tumor, often benign but with malignant potential. Early diagnosis and long-term follow-up are crucial for managing this Schwannoma variant.
Area of Science:
- Neuro-oncology
- Pathology
- Genetics
Background:
- Melanotic Schwannoma (MS) is a rare neoplasm, a variant of Schwannoma, often involving the central nervous system.
- Approximately 50% of MS cases exhibit psammomatous calcifications and can be associated with Carney complex (autosomal dominant inheritance).
- While typically benign, 10% of MS cases show malignant potential with metastatic capabilities, mimicking melanoma.

